Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- biotechnology [1]
- Company / filing name
- Ginkgo Bioworks Holdings, Inc. [2]
- Headquarters location
- Boston [1]
- Founded
- 2008; 2009 [1]
- Legal form
- joint-stock company [1]
- Founders
- Jason Kelly [1]
- Official website
- https://www.ginkgo.bio/; https://www.ginkgobioworks.com [1]
- CIK
- 1830214 [2]
- Country in background record
- United States [1]
- Symbols / exchanges
- DNA (NYSE) [2]
Company positioning and business
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. [3]
Background text: Wikipedia contributors, Ginkgo Bioworks. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: DNA (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [2]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was Ginkgo Bioworks Holdings, Inc. founded?
Founded: 2008; 2009. The linked source provides the background record. [1]
Where is the headquarters of Ginkgo Bioworks Holdings, Inc.?
Headquarters location: Boston. The linked source provides the background record. [1]
Which business sectors are recorded for Ginkgo Bioworks Holdings, Inc.?
Business sectors: biotechnology. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Ginkgo Bioworks (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.